title: Oral glycopyrrolate after the failure of oral oxybutynin in the treatment of primary hyperhidrosis.
authors.affiliation: Dermatology Department, Hospital Costa del Sol, Marbella, Málaga, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Del Boz
authors.affiliation: Dermatology Department, Hospital Costa del Sol, Marbella, Málaga, Spain.|University of Málaga, Málaga, Spain.
authors.forename: J F
authors.initials: JF
authors.lastname: Millán-Cayetano
authors.affiliation: Research Unit, Hospital Costa del Sol, Marbella, Málaga, Spain.|Health Services Research on Chronic Patients Network (REDISSEC), Marbella, Málaga, Spain.
authors.forename: F
authors.initials: F
authors.lastname: Rivas-Ruiz
authors.affiliation: Dermatology Department, Hospital Costa del Sol, Marbella, Málaga, Spain.|Health Services Research on Chronic Patients Network (REDISSEC), Marbella, Málaga, Spain.
authors.forename: M
authors.initials: M
authors.lastname: de Troya-Martín
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D004334:Drug Administration Schedule; D005260:Female; D006024:Glycopyrrolate / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D006945:Hyperhidrosis / Q000188:drug therapy*; D008297:Male; D008333:Mandelic Acids / Q000008:administration & dosage; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D011446:Prospective Studies; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D008333:Mandelic Acids; D018727:Muscarinic Antagonists; C005419:oxybutynin; D006024:Glycopyrrolate